Data / Drug companies / Injection, powder, lyophilized, for suspension
Companies that list injection, powder, lyophilized, for suspension products: 24 companies and 46 products in the FDA NDC directory
The FDA National Drug Code Directory lists 46 products that are injection, powder, lyophilized, for suspension products from 24 companies. The ten largest listers hold 69.6% of them, and the newest started marketing on August 11, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 24
- Products
- 46
- Drugs by generic name
- 14
- Main marketing category
- Drugs for further processing
Companies that list injection, powder, lyophilized, for suspension products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | 11 | injection, powder, lyophilized, for suspension | Drugs for further processing | August 15, 2011 |
| Mylan Institutional LLC | 5 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | October 9, 2025 |
| Synergy Health Ast, LLC | 4 | injection, powder, lyophilized, for suspension | Drugs for further processing | September 8, 2017 |
| Merck Sharp & Dohme LLC | 3 | injection, powder, lyophilized, for suspension | Biologics (BLA) | July 1, 2015 |
| Bavarian Nordic A/s | 2 | injection, powder, lyophilized, for suspension | Biologics (BLA) | December 31, 2025 |
| Bracco Diagnostics Inc | 2 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | April 1, 2021 |
| Slate Run Pharmaceuticals, LLC | 2 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | October 1, 2022 |
| Aadi Bioscience, Inc. | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | December 6, 2021 |
| Abraxis BioScience, LLC | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | February 10, 2005 |
| American Regent, Inc. | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | May 2, 2023 |
| Bamboo US Bidco LCC | 1 | injection, powder, lyophilized, for suspension | Drugs for further processing | February 10, 2005 |
| BluePoint Laboratories | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | July 18, 2025 |
| Cipla USA Inc. | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | April 15, 2025 |
| Curium US LLC | 1 | injection, powder, lyophilized, for suspension | Biologics (BLA) | March 20, 2020 |
| Exelan Pharmaceuticals Inc. | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | August 11, 2026 |
| Hainan Poly Pharm. Co., Ltd. | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | November 14, 2023 |
| Jazz Pharmaceuticals, Inc. | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | August 3, 2017 |
| Meitheal Pharmaceuticals Inc. | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | May 15, 2025 |
| Ningbo Shuangcheng Pharmaceutical Co., Ltd | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | May 15, 2025 |
| NorthStar RxLLC | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | September 10, 2025 |
| Sandoz Inc | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | October 8, 2024 |
| Sanofi Vaccines US Inc. | 1 | injection, powder, lyophilized, for suspension | Biologics (BLA) | May 22, 1953 |
| Sintetica US LLC | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | November 5, 2023 |
| Teva Pharmaceuticals, Inc. | 1 | injection, powder, lyophilized, for suspension | New drug applications (NDA) | July 2, 2024 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Daptomycin | 3 | 25 |
| Sirolimus | 1 | 22 |
| Paclitaxel | 8 | 20 |
| Leucovorin calcium | 3 | 18 |
| Bivalirudin | 1 | 13 |
| Paclitaxel protein-bound particles | 2 | 2 |
| Sulfur hexafluoride | 2 | 1 |
| (daunorubicin and cytarabine) liposome | 1 | 1 |
| Amphotericin b liposome | 1 | 1 |
| Measles, mumps, and rubella virus vaccine live | 1 | 1 |
| Measles, mumps, rubella and varicella virus vaccine live | 1 | 1 |
| Paclitaxel (aibumin-bound) | 1 | 1 |
| Varicella virus vaccine live | 1 | 1 |
| Yellow fever virus strain 17d-204 live antigen | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.